In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. See also Continuous Glucose Monitoring - Coming of Age, also available in PDF format. I'm almost 4 3/4 now, so that means I've had this disease a lot longer in my life than I haven't had it.

Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit.

Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?

PERL (Preventing Early Renal Loss in Diabetes) is a clinical trial for people with type 1 diabetes who have early signs of kidney problems.

Our goal is to test a new way to reduce loss of kidney function using a safe and inexpensive medicine.

To learn more, see Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations. The next morning I asked James, who was 3 at the time, "Where would you like your shot today? Ragnar Hanas offers the most comprehensive book about type 1 diabetes, and one of the best.

This book is updated to include pump therapy, continuous sensing, extensive coverage of social issues, and the latest in research.

We are seeking adults with type 1 diabetes to participate in our study.

Type 1 Diabetes Trial Net is a group of studies looking at the prevention and early treatment of type 1 diabetes.

A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors: The Navigator, G4 Platinum, and Enlite. Increasing Incidence of Type 1 Diabetes in Youth - Twenty years of the Philadelphia Pediatric Diabetes Registry.